Create account

Coverage dated October 26, 2026 to October 27, 2026

STAT+: Moderna CEO on what’s next after success in cancer vaccine

Headline from STAT

Moderna's CEO Stéphane Bancel on what's next after the recent success in cancer vaccine, and how that impacts the company's business strategy.

STAT's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Read the reports

Reports & sources

3 articles, oldest first.

  1. STAT

    STAT+: Moderna CEO on what’s next after success in cancer vaccine (opens STAT)

    Published

    STAT's feed description

    Moderna's CEO Stéphane Bancel on what's next after the recent success in cancer vaccine, and how that impacts the company's business strategy.

  2. Bloomberg

    Moderna CEO Confident Cancer Vaccines Will Work Beyond Melanoma (opens Bloomberg)

    Published

    Bloomberg's feed description

    Moderna Inc. Chief Executive Officer Stephane Bancel said he believes the personalized mRNA cancer vaccine his company is developing with Merck & Co. will work in a variety of tumors, directly addressing a key issue shrouding the company’s future.

  3. The Boston Globe

    Moderna CEO on what’s next after success in cancer vaccine (opens The Boston Globe)

    Published

    The Boston Globe's feed description

    Stéphane Bancel said the Cambridge-based company intends to soon seek FDA approval for intismeran.

STAT+: Moderna CEO on what’s next after success in cancer vaccine | Since Then